DOI: 10.4244/EIJV13I3A41

In memoriam Alfonso Medina Fernandez-Aceituno, MD, 1946-2017

Manuel Pan1*, MD, on behalf of the European Bifurcartion Club Committee: Remo Albiero2, MD; Adrian Banning3, MD, PhD; Francesco Burzotta4, MD, PhD; Yiannis S. Chatzizisis5, MD, PhD, FAHA, FACC; Alaide Chieffo6, MD; Olivier Darremont7, MD; Miroslaw Ferenc8, MD; David Hildick-Smith9, MD; Jens Flensted Lassen10, MD, PhD; Thierry Lefèvre11, MD; Yves Louvard11, MD; Goran Stankovic12, MD, PhD

“Simplicity is the ultimate sophistication” – Leonardo da Vinci

Alfonso Medina studied medicine at the University of Granada (Spain). After obtaining his MD, he received training in Cardiology at the Fundacion Jimenez Diaz in Madrid and at the Parkland Memorial Hospital in Dallas. In 1975, he arrived at the Hospital Nuestra Señora del Pino in Las Palmas de Gran Canaria (Spain), where he was appointed head of the Department of Cardiology. He worked tirelessly in this hospital (later replaced by the new Dr Negrin Hospital) until he reached retirement age in 2016. There, he developed an intense clinical, research and teaching activity over more than 40 years. He was also a brilliant speaker with a great sense of humour. He was the inventor of very ingenious devices, for instance the coronary variable length balloon catheter (1994) and the adjustable vascular introducer for balloon valvuloplasty (1989). Professor at the University of Las Palmas, he was the master of many generations of cardiologists. In 1987, he started a fruitful scientific relationship with Dr Jose Suarez de Lezo from Cordoba. Together they founded the CORPAL (Cordoba-Las Palmas) group, which made a significant number of important contributions in the field of coronary, valvular and congenital heart disease over a period of 30 years. In 2005, he became a member of the European Bifurcation Club (EBC). While he was attending the first EBC meeting in Bordeaux, his classification of bifurcation coronary lesions was proclaimed as the unique EBC classification by total consensus. Since then, this contribution has been widely used in papers and in cardiology congresses. The article in the Revista Española de Cardiologia (2006) describing the Medina classification has reached a record number of citations (388 according to the Scopus database). For more than 10 years he continued to attend the EBC meeting, contributing original ideas, such as the “eyebrow sign” (IVUS predictor of side branch occlusion) or the SMS technique as an alternative to the kissing balloon. In Valencia (2007), he was honoured by the members of the club for his contributions in the field of bifurcations. Over the following years, he continued participating in and enjoying the EBC meetings until he recently passed away. We will miss him in future congresses, but his legacy will always remain in the ambience of the club.

Volume 13 Number 3
Jun 20, 2017
Volume 13 Number 3
View full issue


Key metrics

Suggested by Cory
Trending articles
335.55

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved